Vir Biotechnology Executive Compensation
Vir Biotechnology appointed Suzanne Topalian, M.D., to its Board of Directors and the Science and Technology Committee, effective October 27, 2026. As a non-employee director, she will receive standard cash and equity compensation, including stock options and restricted stock units under the company's 2019 Equity Incentive Plan. The board size was increased from eight to nine members to accommodate the appointment.
- Counterparty
- Suzanne Topalian, M.D.